1084.8000 -35.20 (-3.14%)
NSE Oct 01, 2026 15:31 PM
Volume: 340.8K
 

logo
Strides Pharma Science Ltd.
02 Jul 2026, 12:00AM
1084.80
-3.14%
Geojit BNP Paribas
The company reiterated its FY28 revenue target of $400 million, supported by a pipeline of 60+ pending low-competition U.S. product launches. Management also remains optimistic about other regulated markets, where portfolio expansion and new customer additions are expected to drive stronger growth and gradually scale revenues to levels comparable to the U.S. business....
Strides Pharma Science Ltd. is trading below its 30 day SMA of 1115.5
More from Strides Pharma Science Ltd.
Recommended